MARY SCOTT: Open Payments
NPI 1124177514 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 30 payments from 15 companies in 2025. Trend: 2023 $2,144 · 2024 $828 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $231 |
| Teva Pharmaceuticals USA, Inc. | 2 | $196 |
| Amneal Pharmaceuticals LLC | 2 | $141 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| SK Life Science, Inc. | 2 | $34 |
| Merz Pharmaceuticals, LLC | 2 | $32 |
| ACADIA Pharmaceuticals Inc | 2 | $30 |
| Genentech USA, Inc. | 1 | $25 |
| TG Therapeutics, Inc. | 1 | $23 |
| UCB, Inc. | 1 | $18 |
Products named: VYALEV, AUSTEDO XR, CREXONT, KESIMPTA, Xeomin, NUPLAZID, Ocrevus Zunovo, BRIUMVI.
Industry payments across OH — which companies pay providers there.
